First U.S. Implant of St. Jude’s First-to-Market “CRT-D”

| Printer friendly version

St. Jude Medical, Inc. recently announced the U.S. launch and the first U.S. implant of its Quadra Assure MP cardiac resynchronization therapy defibrillator (CRT-D).  The Quadra Assura MP features St. Jude Medical’s first-to-market  MultiPoint Pacing (MPP) technology.  The device received CE Mark Approval for MRI Compatibility in December 2015 and the MPP technology received U.S. FDA approval earlier this year.  According to the press release, the first implant of the Quadra Assura MP took place at Saint Francis Hospital in Hartford, Connecticut.

Heart failure patients frequently experience ventricle contraction or beating that is out of sync.  CRT synchronizes the ventricle contraction.  According to the press release, the first-to market MPP technologies allow physicians to pace multiple locations on the left side of the patient’s heart.  According to the American Heart Association, “heart failure (HF) is a chronic, progressive condition in which the heart muscle is unable to pump enough blood through to meet the body’s needs for blood and oxygen.”  The condition affects over 5.8 million in the USA and over 23 million worldwide.  Despite the success of CRT, according to a recent study, one third of the HF patients fail to respond to CRT.  The same study shows that MPP optimizes the response of such non-responsive patients to CRT.  According to St. Jude, MPP is also featured on St. Jude Medical’s Quadra Allure MP CRT-pacemaker (CRT-P) and two new Quartet Quadripolar LV Leads.

St. Jude Medical, Quadra Asssura CRT-D, Quadra Assura MP, MR conditional labeling, CE Mark

Regarding the first implant, Dr. Mark D. Carlson, Chief Medical Officer and Vice President, Global Clinical Affairs, at St. Jude Medical, stated:

St. Jude Medical developed and established a new standard of care for CRT with quadripolar pacing. We are excited to bring the next-generation MultiPoint Pacing technology to market, giving physicians additional options to improve patient response.

Dr. Neal Lippman, electrophysiologist with Arrhythmia Consultants of Connecticut, added:

We are now able to offer St. Jude Medical’s new MultiPoint Pacing technology for our patients whose heart failure condition is difficult to manage. It is important for us to have this option to individualize patient care and help improve response to therapy.

According to its website, St. Jude Medical is a global medical device manufacturer, headquartered in St. Paul, Minnesota and focuses on six key treatment areas: heart failure, arrhythmias, vascular disease, structural heart, chronic pain, and neurological diseases.

Sabrina Wang
Sabrina Wang is an associate in our Orange County office. Ms. Wang received her Bachelor's Degree in Bioengineering in 2007 from National University of Singapore. After graduation, she worked as an engineer developing orthopedic devices in Utah and Singapore. In 2015, Ms. Wang graduated from the University of Virginia School of Law. While attending law school, Ms. Wang served on the Article Review Board of Virginia Journal of Law & Technology in her second year. Ms. Wang was a summer associate at the firm in 2014 and joined the firm as an associate in 2015.
Click here to read full bio
View all posts published by Sabrina Wang »

Leave a Reply

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.